EC Number | Application | Comment | Organism |
---|---|---|---|
2.3.1.250 | drug development | PORCN is a prominent target for developing inhibitors for various cancers | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.3.1.250 | 2-(4-(2-methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetamide | i.e. C59 | Homo sapiens | |
2.3.1.250 | 2-[5-methyl-6-(2-methylpyridin-4-yl)pyridin-3-yl]-N-(5-pyrazin-2-ylpyridin-2-yl)acetamide | i.e. LGK-974 | Homo sapiens |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
2.3.1.250 | endoplasmic reticulum | endoplasmic reticulum-resident integral membrane enzyme | Homo sapiens | 5783 | - |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.250 | (9Z)-hexadec-9-enoyl-CoA + [Wnt]-L-serine | Homo sapiens | the enzyme catalyzes posttranslational modification of Wnts with palmitoleic acid. PORCN is necessary and sufficient for Wnt acylation. PORCN intimately recognizes the local structure of Wnt around the site of acylation | CoA + [Wnt]-O-(9Z)-hexadec-9-enoyl-L-serine | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.3.1.250 | Homo sapiens | Q9H237 | - |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
2.3.1.250 | - |
Homo sapiens |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.250 | (9Z)-hexadec-9-enoyl-CoA + [Wnt]-L-serine | the enzyme catalyzes posttranslational modification of Wnts with palmitoleic acid. PORCN is necessary and sufficient for Wnt acylation. PORCN intimately recognizes the local structure of Wnt around the site of acylation | Homo sapiens | CoA + [Wnt]-O-(9Z)-hexadec-9-enoyl-L-serine | - |
? | |
2.3.1.250 | (9Z)-hexadec-9-enoyl-CoA + [Wnt]-L-serine | there is an increase in the catalytic activity from hexanoyl-CoA to decanoyl-CoA, after which there is an abrupt drop for dodecanoyl-CoA. Upon further increase in fatty acyl chain length, the activity stays at approximately the same level until the unsaturated palmitoleoyl-CoA, which is the best substrate | Homo sapiens | CoA + [Wnt]-O-(9Z)-hexadec-9-enoyl-L-serine | - |
? | |
2.3.1.250 | decanoyl-CoA + [Wnt]-L-serine | about 30% of the activity as compared to (9Z)-hexadec-9-enoyl-CoA. There is an increase in the catalytic activity from hexanoyl-CoA to decanoyl-CoA, after which there is an abrupt drop for dodecanoyl-CoA. Upon further increase in fatty acyl chain length, the activity stays at approximately the same level until the unsaturated palmitoleoyl-CoA, which is the best substrate | Homo sapiens | CoA + [Wnt]-O-decanoyl-L-serine | - |
? | |
2.3.1.250 | dodecanoyl-CoA + [Wnt]-L-serine | about 15% of the activity as compared to (9Z)-hexadec-9-enoyl-CoA. There is an increase in the catalytic activity from hexanoyl-CoA to decanoyl-CoA, after which there is an abrupt drop for dodecanoyl-CoA. Upon further increase in fatty acyl chain length, the activity stays at approximately the same level until the unsaturated palmitoleoyl-CoA, which is the best substrate | Homo sapiens | CoA + [Wnt]-O-dodecanoyl-L-serine | - |
? | |
2.3.1.250 | hexanoyl-CoA + [Wnt]-L-serine | about 20% of the activity as compared to (9Z)-hexadec-9-enoyl-CoA. There is an increase in the catalytic activity from hexanoyl-CoA to decanoyl-CoA, after which there is an abrupt drop for dodecanoyl-CoA. Upon further increase in fatty acyl chain length, the activity stays at approximately the same level until the unsaturated palmitoleoyl-CoA, which is the best substrate | Homo sapiens | CoA + [Wnt]-O-hexanoyl-L-serine | - |
? | |
2.3.1.250 | octanoyl-CoA + [Wnt]-L-serine | about 25% of the activity as compared to (9Z)-hexadec-9-enoyl-CoA. There is an increase in the catalytic activity from hexanoyl-CoA to decanoyl-CoA, after which there is an abrupt drop for dodecanoyl-CoA. Upon further increase in fatty acyl chain length, the activity stays at approximately the same level until the unsaturated palmitoleoyl-CoA, which is the best substrate | Homo sapiens | CoA + [Wnt]-O-octanoyl-L-serine | - |
? | |
2.3.1.250 | tetradecanoyl-CoA + [Wnt]-L-serine | about 10% of the activity as compared to (9Z)-hexadec-9-enoyl-CoA. There is an increase in the catalytic activity from hexanoyl-CoA to decanoyl-CoA, after which there is an abrupt drop for dodecanoyl-CoA. Upon further increase in fatty acyl chain length, the activity stays at approximately the same level until the unsaturated palmitoleoyl-CoA, which is the best substrate | Homo sapiens | CoA + [Wnt]-O-tetradecanoyl-L-serine | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.3.1.250 | porcupine | - |
Homo sapiens |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
2.3.1.250 | 0.00067 | - |
pH 7.3, 25°C | Homo sapiens | 2-(4-(2-methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetamide |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.3.1.250 | metabolism | the enzyme catalyzes posttranslational modification of Wnts with palmitoleic acid. This unique form of lipidation with palmitoleic acid is a vital step in the biogenesis and secretion of Wnt | Homo sapiens |